when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
LOFEXIDINE HYDROCHLORIDE
LOFEXIDINE HYDROCHLORIDE
Opium Withdrawal Syndrome$BICX BioCorRx Inc.1 cat
Marketed
fosfomycin disodium
Contepo (fosfomycin disodium [INN])
Pyelonephritis Meitheal Pharmaceuticals Inc1 cat
Marketed
Celebrex
Celecoxib Greenstone (celecoxib)
Osteoarthritis Pain Greenstone LLC11 cat
Marketed

page 31 of 231

131

Iron Poisoning

Reddy US Therapeutics Inc

7 cat

Marketed

Spevigo (spesolimab)

Pyoderma Gangrenosum Boehringer Ingelheim International GmbH5 cat

Marketed

STIMUFEND (PEGFILGRASTIM-FPGK)

no indication Fresenius Kabi USA LLC4 cat

Marketed

atrasentan hydrochloride

Vanrafia (atrasentan hydrochloride)

IgA Nephropathy (Berger's Disease)$NVS NOVARTIS AG2 cat

Marketed

PROPARACAINE HYDROCHLORIDE

PROPARACAINE HYDROCHLORIDE

Local Anesthetic Effect$ALC ALCON INC1 cat

Marketed

HADLIMA (ADALIMUMAB-BWWD)

no indication Samsung Bioepis Co Ltd12 cat

Marketed

Balversa (erdafitinib)

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON11 cat

Marketed

Envarsus XR (tacrolimus)

Kidney Transplant Rejection Veloxis Pharmaceuticals Inc8 cat

Marketed

triamcinolone acetonide Rising

Triamcinolone Acetonide

Atopic Dermatitis (Atopic Eczema) Rising Pharma Holdings Inc6 cat

Marketed

BUSPIRONE HYDROCHLORIDE

BUSPIRONE HYDROCHLORIDE

Anxiety Disorders Zydus Pharmaceuticals USA Inc5 cat

Marketed

Tezspire (tezepelumab-ekko)

Eosinophilic Esophagitis$AMGN AMGEN INC4 cat

Marketed

riboflavin 5'-phosphate sodium

Photrexa Viscous (riboflavin 5'-phosphate sodium)

Keratoconus$GKOS GLAUKOS Corp1 cat

Marketed

General Anesthetic Effect Piramal Critical Care Inc18 cat

Marketed

YUFLYMA (ADALIMUMAB-AATY)

no indication Celltrion Inc14 cat

Marketed

AMJEVITA (ADALIMUMAB-ATTO)

no indication$AMGN AMGEN INC13 cat

Marketed

HYRIMOZ (ADALIMUMAB-ADAZ)

no indication Sandoz Inc13 cat

Marketed

CYLTEZO (ADALIMUMAB-ADBM)

no indication Boehringer Ingelheim Corp12 cat

Marketed

Ztalmy (ganaxolone)

Seizures Marinus Pharmaceuticals Inc8 cat

Marketed

palopegteriparatide

Yorvipath (palopegteriparatide)

Hypoparathyroidism Ascendis Pharma Inc2 cat

Marketed

PANTOPRAZOLE SODIUM

PANTOPRAZOLE SODIUM

Corrosive Esophagitis (Erosive Esophagitis) Knack Pharmaceuticals Inc14 cat

Marketed

fenfluramine hydrochloride

Fintepla (fenfluramine hydrochloride)

Unspecified Genetic Disorders UCB SA11 cat

Marketed

Generalized Seizures UCB SA6 cat

Marketed

Lytgobi (futibatinib)

Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat

Marketed

upadacitinib tartrate ER

Rinvoq (upadacitinib tartrate)

Vitiligo$ABBV AbbVie Inc.19 cat

Marketed

Ongentys (opicapone [INN])

Parkinson's Disease$AMRX Amneal Pharmaceuticals, Inc.3 cat

Marketed

Rinvoq LQ (upadacitinib)

Polyarticular Juvenile Idiopathic Arthritis (PJIA)$ABBV AbbVie Inc.3 cat

Marketed

Praluent (alirocumab)

Heterozygous Familial Hypercholesterolemia (heFH) Sanofi-Aventis US LLC14 cat